Literature DB >> 15950442

Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia.

Adrienne C Lahti1, Martin A Weiler, Deborah R Medoff, Carol A Tamminga, Henry H Holcomb.   

Abstract

Using PET with (15)O water, we characterized the time course of functional brain changes following the acute administration of a first- and a second-generation antipsychotic. Volunteers with schizophrenia were scanned while drug-free (baseline) and after single dose administration of haloperidol (n=6) or olanzapine (n=6) during a time course adapted to their plasma kinetics. To obtain brain location information, we contrasted each post-drug scan to baseline-acquired scans. We plotted the regional cerebral blood flow (rCBF) extracted in these locations and calculated the kinetic characteristics of the curves. Further, we compared and contrasted the rCBF changes induced by the drugs over the first 4 h post-drug administration. Dorsal and ventral striatum, thalamus and anterior cingulate cortex were activated with haloperidol, while frontal, temporal and cerebellum regions evidenced reduced flow. With olanzapine, ventral striatum, anterior cingulate and temporal cortices evidenced increases, and thalamus and lingual cortex decreases, in rCBF. Both drugs activated the caudate nucleus. Haloperidol induced greater activation of the dorsal striatum than did olanzapine. These data reveal important differences in patterns of brain activation between the drugs. Differences in the involvement in basal ganglia parallel known differences between the drugs in the emergence of acute EPS upon emergency administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950442     DOI: 10.1016/j.pscychresns.2005.02.006

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  32 in total

1.  First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.

Authors:  Kjetil N Jørgensen; Ragnar Nesvåg; Sindre Gunleiksrud; Andrea Raballo; Erik G Jönsson; Ingrid Agartz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-07       Impact factor: 5.270

2.  Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.

Authors:  Florian Schlagenhauf; Georg Juckel; Michael Koslowski; Thorsten Kahnt; Brian Knutson; Theresa Dembler; Thorsten Kienast; Jürgen Gallinat; Jana Wrase; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2007-12-21       Impact factor: 4.530

3.  Effects of amisulpride on human resting cerebral perfusion.

Authors:  Roberto Viviani; Heiko Graf; Maike Wiegers; Birgit Abler
Journal:  Psychopharmacology (Berl)       Date:  2013-04-13       Impact factor: 4.530

4.  Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia.

Authors:  Elyse J Cadena; David M White; Nina V Kraguljac; Meredith A Reid; Ripu Jindal; Roland Matthew Pixley; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2018-08-08       Impact factor: 4.939

5.  Population pharmacokinetics analysis of olanzapine for Chinese psychotic patients based on clinical therapeutic drug monitoring data with assistance of meta-analysis.

Authors:  Anyue Yin; Dewei Shang; Yuguan Wen; Liang Li; Tianyan Zhou; Wei Lu
Journal:  Eur J Clin Pharmacol       Date:  2016-04-27       Impact factor: 2.953

6.  Transcriptional dysregulation causes altered modulation of inhibition by haloperidol.

Authors:  Lillian J Brady; Aundrea F Bartley; Qin Li; Laura J McMeekin; John J Hablitz; Rita M Cowell; Lynn E Dobrunz
Journal:  Neuropharmacology       Date:  2016-07-29       Impact factor: 5.250

7.  Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei--a combined MRI and H2(15)O PET study.

Authors:  Christopher M Weise; Pradeep Thiyyagura; Eric M Reiman; Kewei Chen; Jonathan Krakoff
Journal:  Neuroimage       Date:  2011-12-21       Impact factor: 6.556

8.  Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.

Authors:  James Edward Bryant; Michael Frölich; Steve Tran; Meredith Amanda Reid; Adrienne Carol Lahti; Nina Vanessa Kraguljac
Journal:  J Psychiatr Res       Date:  2019-07-27       Impact factor: 4.791

Review 9.  Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia.

Authors:  Fulvio A Scorza; Andrea Schmitt; Roberta M Cysneiros; Ricardo M Arida; Esper A Cavalheiro; Wagner F Gattaz
Journal:  Clinics (Sao Paulo)       Date:  2010-05       Impact factor: 2.365

10.  Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.

Authors:  Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; Karen L Cropsey
Journal:  Neuropsychopharmacology       Date:  2009-08-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.